Sorafenib enhances pemetrexed cytotoxicity through an autophagy- dependent mechanism in cancer cells

Pemetrexed (ALIMTA) is a folate anti-metabolite that has been approved for the treatment of non-small cell lung cancer, and has been shown to stimulate autophagy. In the present study, we sought to further understand the role of autophagy in the response to pemetrexed and to test if combination ther...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Bareford, M Danielle, Hamed, Hossein A, Tang, Yong, Cruickshanks, Nichola, Burow, Matthew E, Fisher, Paul B, Moran, Richard G, Nephew, Kenneth P, Grant, Steven, Dent, Paul
Format: Artigo
Idioma:Inglês
Publicat: Landes Bioscience 2011
Matèries:
Autophagic Punctum
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3210312/
https://ncbi.nlm.nih.gov/pubmed/21814046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/auto.7.10.17029
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars